Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes

American Journal of Cardiology

Volumn 92, Issue 2, 2003, Pages 136-140

  Bhatt, Deepak L ^a   Chew, Derek P ^b   Lincoff, A Michael ^b   Simoons, Maarten L ^b   Harrington, Robert A ^b   Ommen, Steve R ^b   Jia, Gang ^b   Topol, Eric J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE MARKER; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; TREATMENT OUTCOME;

EID: 0038645353     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00527-7     Document Type: Article

References (25)

1. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study. N Engl J Med. 338:1998;1498-1505.
2. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina Receptor Suppression Using Integrilin Therapy . N Engl J Med. 339:1998;436-443.
3. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Circulation. 97:1998;2386-2395.
4. Bhatt D.L., Topol E.J. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA. 284:2000;1549-1558.
5. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 101:2000;2149-2153.
6. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
7. Biasucci L.M., Liuzzo G., Grillo R.L., Caligiuri G., Rebuzzi A.G., Buffon A., Summaria F., Ginnetti F., Fadda G., Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 99:1999;855-860.
8. Tommasi S., Carluccio E., Bentivoglio M., Buccolieri M., Mariotti M., Politano M., Corea L. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol. 83:1999;1595-1599.
9. Kaartinen M., van der Wal A.C., van der Loos C.M., Piek J.J., Koch K.T., Becker A.E., Kovanen P.T. Mast cell infiltration in acute coronary syndromes implications for plaque rupture . J Am Coll Cardiol. 32:1998;606-612.
10. George S.J. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr Opin Lipidol. 9:1998;413-423.
11. Phipps R.P. Atherosclerosis the emerging role of inflammation and the CD40-CD40 ligand system . Proc Natl Acad Sci USA. 97:2000;6930-6932.
12. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction a Thrombolysis In Myocardial Infarction 10 substudy . Circulation. 102:2000;2329-2334.
13. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol. 87:2001;636-639.
14. Hajj-Ali R., Zareba W., Ezzeddine R., Moss A.J. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 88:2001;1221-1224.
15. Modan B., Schor S., Shani M. Acute myocardial infarction. Prognostic value of white blood cell count and blood glucose level. JAMA. 233:1975;266-267.
16. Ernst E., Hammerschmidt D.E., Bagge U., Matrai A., Dormandy J.A. Leukocytes and the risk of ischemic diseases. JAMA. 257:1987;2318-2324.
17. Green S.M., Vowels J., Waterman B., Rothrock S.G., Kuniyoshi G. Leukocytosis a new look at an old marker for acute myocardial infarction . Acad Emerg Med. 3:1996;1034-1041.
18. Furman M.I., Becker R.C., Yarzebski J., Savegeau J., Gore J.M., Goldberg R.J. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol. 78:1996;945-948.
19. Boersma E., Pieper K.S., Steyerberg E.W., Wilcox R.G., Chang W.C., Lee K.L., Akkerhuis K.M., Harrington R.A., Deckers J.W., Armstrong P.W., et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 101:2000;2557-2567.
20. Meier B., Ramamurthy S. Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn. 36:1995;295-297.
21. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
22. Invasive compared with non-invasive treatment in unstable coronary-artery disease FRISC II prospective randomised multicentre study . Lancet. 354:1999;708-715.
23. Heeschen C., Hamm C.W., Bruemmer J., Simoons M.L. Predictive value of C-reactive protein and troponin T in patients with unstable angina a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial . J Am Coll Cardiol. 35:2000;1535-1542.
24. Chan A.W., Bhatt D.L., Chew D.P., Reginelli J., Schneider J.P., Topol E.J., Ellis S.G. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation. 107:2003;1750-1756.
25. Bhatt D.L., Topol E.J. Need to test the arterial inflammation hypothesis. Circulation. 106:2002;136-140.